Statin Recapture Therapy Before Coronary Artery Bypass Grafting
Status:
Completed
Trial end date:
2019-09-24
Target enrollment:
Participant gender:
Summary
Patients with coronary artery disease requiring coronary artery bypass grafting (CABG) are at
risk for postoperative complications after surgery. The StaRT-CABG trial is the first
large-scale (2,630 patients) that will investigate whether an additional treatment with
statins (lipid-lowering medication) in high doses before CABG surgery can reduce the
incidence of major post-surgery complications including death, myocardial infarction and
stroke. The StaRT-CABG trial will be recruiting patients from 8 cardiac surgery centres in
Germany and is expected to provide relevant clinical data on the efficacy of this novel
treatment in order to optimize the care for all patients undergoing CABG.